Phio Pharmaceuticals Corp. (PHIO)
Phio Pharmaceuticals Announces Participation in the Life Sciences Investor Forum on June 24-25, 2026
Phio Pharmaceuticals Announces Participation in the Life Sciences Investor Forum on June 24-25, 2026
Compugen Presents a Trial-in-Progress Poster on the MAIA-ovarian Adaptive Platform Trial at ESMO Gynaecological Cancers Congress
Enanta Pharmaceuticals Announces Advancement of its Zelicapavir Clinical Development Program for the Treatment of Respiratory Syncytial Virus (RSV)
Nephros to Host Virtual Investor Event: “Beyond Filtration: The Nephros Model in Action”
Hi*Ball Energy Arrives in the UK, Leading a New Wave of Clean Energy
Chicago Atlantic Real Estate Finance, Inc. and Chicago Atlantic BDC, Inc. Announce Definitive Merger Agreement
Veteran Investor and Widely Followed Market Analyst Shah Gilani Calls VENU Stock “Significantly Undervalued”
Novocure Announces Topline Data from the Phase 3 TRIDENT Trial Evaluating Earlier Use of Tumor Treating Fields Therapy in Newly Diagnosed Glioblastoma
Deluxe to Acquire Celero Commerce, Accelerating Transformation Toward Payments and Data Solutions Scale
Aurora Mobile and AI Storm Enter into Business Partnership to Advance AI-Powered Customer Operations in Japan